Correlation Between Oragenics and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oragenics and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oragenics and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oragenics and vTv Therapeutics, you can compare the effects of market volatilities on Oragenics and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oragenics with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oragenics and VTv Therapeutics.

Diversification Opportunities for Oragenics and VTv Therapeutics

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Oragenics and VTv is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Oragenics and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and Oragenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oragenics are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of Oragenics i.e., Oragenics and VTv Therapeutics go up and down completely randomly.

Pair Corralation between Oragenics and VTv Therapeutics

Given the investment horizon of 90 days Oragenics is expected to under-perform the VTv Therapeutics. In addition to that, Oragenics is 1.73 times more volatile than vTv Therapeutics. It trades about -0.11 of its total potential returns per unit of risk. vTv Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest  2,200  in vTv Therapeutics on August 30, 2024 and sell it today you would lose (649.00) from holding vTv Therapeutics or give up 29.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Oragenics  vs.  vTv Therapeutics

 Performance 
       Timeline  
Oragenics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oragenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
vTv Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, VTv Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Oragenics and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oragenics and VTv Therapeutics

The main advantage of trading using opposite Oragenics and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oragenics position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind Oragenics and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.